LATIN AMERICA MULTIPLEX ASSAY MARKET 2021-2028
MARKET OUTLOOK
Triton’s research report suggests that the Latin American multiplex assay market is predicted to showcase revenue growth at a CAGR of 6.74% during the period 2021-2028. Mexico, Brazil, and Rest of Latin America outline the market in this region.
In Mexico, the growing aging population is estimated to support the studied market’s growth majorly. As per estimates, the geriatric population above 65 years is likely to proliferate by 2050. Here, this population base is expected to be more prone to chronic conditions, increasing the need for better healthcare services. Furthermore, among various conditions, tuberculosis is highly endemic in the country, especially in Southern Mexico. This has led to the adoption of multiplex PCR, which plays a major role in detecting and quantifying Mycobacterium tuberculosis DNA. Hence, all these factors are estimated to create new opportunities for the multiplex assay market within Mexico.
In Rest of Latin America, the rising burden of cancer and growing investments in R&D are likely to fuel the growth of the market. Chile is among the major countries with the highest GDP per capita in the region. This has led to the rise in healthcare expenditure across the country, which positively impacts the diagnostic equipment adoption rate. Furthermore, the aging population is likely to grow by 2030, amplifying the demand for effective healthcare services. Thus, the increasing healthcare expenditure and surging geriatric population are expected to boost the multiplex assay market on a progressive path.
COMPETITIVE OUTLOOK
The distinguished companies in the multiplex assay market are F Hoffmann La Roche, Thermo Fisher Scientific Inc, Qiagen NV, Bio Techne corporation, Siemens Healthineers AG, Luminex Corporation, and Bio Rad Laboratories Inc.
- 1. LATIN AMERICA MULTIPLEX ASSAY MARKET - SUMMARY
- 2. INDUSTRY OUTLOOK
- 2.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
- 2.2. KEY INSIGHTS
- 2.3. PORTER’S FIVE FORCES MODEL
- 2.3.1. THREAT OF NEW ENTRANTS
- 2.3.2. THREAT OF SUBSTITUTE PRODUCTS
- 2.3.3. BARGAINING POWER OF BUYERS
- 2.3.4. BARGAINING POWER OF SUPPLIERS
- 2.3.5. COMPETITIVE RIVALRY
- 2.4. KEY BUYING OUTLOOK
- 2.5. MARKET ATTRACTIVENESS INDEX
- 2.6. VENDOR SCORECARD
- 2.7. KEY MARKET STRATEGIES
- 2.7.1. CONTRACTS AND PARTNERSHIPS
- 2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
- 2.7.3. ACQUISITIONS & MERGERS
- 2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
- 2.8. KEY DRIVERS
- 2.8.1. ADOPTION OF PERSONALIZED MEDICINES
- 2.8.2. HIGH ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
- 2.9. KEY RESTRAINTS
- 2.9.1. DEARTH OF SKILLED PROFESSIONALS
- 2.9.2. LEGAL TRENDS RELATED TO ENVIRONMENTAL SAFETY
- 2.10. KEY OPPORTUNITIES
- 2.10.1. FUNDING FOR R&D ACTIVITIES BY VARIOUS GOVERNMENT AGENCIES AND COMPANIES
- 2.10.2. EMERGING ECONOMIES OFFERING LUCRATIVE GROWTH OPPORTUNITIES
- 3. LATIN AMERICA MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
- 3.1. REAGENTS AND CONSUMABLES
- 3.2. INSTRUMENTS AND ACCESSORIES
- 3.3. SOFTWARE AND SERVICES
- 4. LATIN AMERICA MULTIPLEX ASSAY MARKET - BY TYPE
- 4.1. PROTEIN-BASED MULTIPLEX ASSAY
- 4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY
- 4.3. OTHER MULTIPLEX ASSAYS
- 5. LATIN AMERICA MULTIPLEX ASSAY MARKET - BY APPLICATION
- 5.1. RESEARCH AND DEVELOPMENT
- 5.2. CLINICAL DIAGNOSTICS
- 5.3. COMPANION DIAGNOSTICS
- 6. LATIN AMERICA MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
- 6.1. MULTIPLEX PROTEIN MICROARRAY
- 6.2. MULTIPLEX PCR
- 6.3. OTHER TECHNOLOGIES
- 7. LATIN AMERICA MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICALS
- 7.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 7.2. RESEARCH INSTITUTES
- 7.3. CLINICAL LABORATORIES
- 7.4. HOSPITALS
- 8. LATIN AMERICA MULTIPLEX ASSAY MARKET – COUNTRY OUTLOOK
- 8.1. COUNTRY ANALYSIS
- 8.1.1. BRAZIL
- 8.1.2. MEXICO
- 8.1.3. REST OF LATIN AMERICA
- 9. COMPETITIVE LANDSCAPE
- 9.1. ABCAM
- 9.2. AGILENT TECHNOLOGIES INC
- 9.3. BECTON DICKINSON AND COMPANY
- 9.4. BIO RAD LABORATORIES INC
- 9.5. BIO TECHNE CORPORATION
- 9.6. F HOFFMANN LA ROCHE
- 9.7. ILLUMINA INC
- 9.8. LUMINEX CORPORATION
- 9.9. MERCK MILLIPORE
- 9.10. MESO SCALE DIAGNOSTICS LLC
- 9.11. OLINK PROTEOMICS AB
- 9.12. QIAGEN NV
- 9.13. RANDOX LABORATORIES LTD
- 9.14. SEEGENE INC
- 9.15. SIEMENS HEALTHINEERS AG
- 9.16. THERMO FISHER SCIENTIFIC INC
- 10. RESEARCH METHODOLOGY & SCOPE
- 10.1. RESEARCH SCOPE & DELIVERABLES
- 10.1.1. OBJECTIVES OF STUDY
- 10.1.2. SCOPE OF STUDY
- 10.2. SOURCES OF DATA
- 10.2.1. PRIMARY DATA SOURCES
- 10.2.2. SECONDARY DATA SOURCES
- 10.3. RESEARCH METHODOLOGY
- 10.3.1. EVALUATION OF PROPOSED MARKET
- 10.3.2. IDENTIFICATION OF DATA SOURCES
- 10.3.3. ASSESSMENT OF MARKET DETERMINANTS
- 10.3.4. DATA COLLECTION
- 10.3.5. DATA VALIDATION & ANALYSIS
- LIST OF TABLES
- TABLE 1: LATIN AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
- TABLE 2: VENDOR SCORECARD
- TABLE 3: CONTRACTS AND PARTNERSHIPS
- TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
- TABLE 5: ACQUISITIONS & MERGERS
- TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
- TABLE 7: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
- TABLE 8: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
- TABLE 9: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
- TABLE 10: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
- TABLE 11: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
- TABLE 12: LATIN AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
- LIST OF FIGURES
- FIGURE 1: LATIN AMERICA MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)
- FIGURE 2: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2020 & 2028 (IN %)
- FIGURE 3: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
- FIGURE 4: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
- FIGURE 5: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
- FIGURE 6: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020 & 2028 (IN %)
- FIGURE 7: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
- FIGURE 8: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
- FIGURE 9: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
- FIGURE 10: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
- FIGURE 11: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
- FIGURE 12: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
- FIGURE 13: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
- FIGURE 14: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
- FIGURE 15: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
- FIGURE 16: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
- FIGURE 17: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
- FIGURE 18: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
- FIGURE 19: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
- FIGURE 20: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
- FIGURE 21: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
- FIGURE 22: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
- FIGURE 23: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
- FIGURE 24: BRAZIL MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)
- FIGURE 25: MEXICO MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)
- FIGURE 26: REST OF LATIN AMERICA MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)